Skip to content

Clinical trials

Phase 2 Neutropenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 2 Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20035
20043
20052
20063
20074
20082
20093
20102
20114
20123
20135
20142
20152
20162
20172
20181
20191
20201
20221
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting6
Terminated6
Unknown status4
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
National Heart, Lung, and Blood Institute (NHLBI)6
Alliance for Clinical Trials in Oncology2
EVIVE Biotechnology2
GERCOR - Multidisciplinary Oncology Cooperative Group2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
Affiliated Hospital of Nantong University1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia68
Breast Neoplasms13
Thrombocytopenia12
Leukemia10
Anemia9
Febrile Neutropenia7
Leukemia, Myeloid, Acute7
Myelodysplastic Syndromes6
Neoplasms5
Anemia, Aplastic4

Trials

Showing 26 to 50 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.